Mice deficient in dihydrolipoyl succinyl transferase show increased vulnerability to mitochondrial toxins. Academic Article uri icon

Overview

abstract

  • The activity of a key mitochondrial tricarboxylic acid cycle enzyme, alpha-ketoglutarate dehydrogenase complex (KGDHC), declines in many neurodegenerative diseases. KGDHC consists of three subunits. The dihydrolipoyl succinyl transferase (DLST) component is unique to KGDHC. DLST(+/-) mice showed reduced mRNA and protein levels and decreased brain mitochondrial KGDHC activity. Neurotoxic effects of mitochondrial toxins were exacerbated in DLST(+/-) mice. MPTP produced a significantly greater reduction of striatal dopamine and tyrosine hydroxylase-positive neurons in the substantia nigra pars compacta of DLST(+/-) mice. DLST deficiency enhanced the severity of lipid peroxidation in the substantia nigra after MPTP treatment. Striatal lesions induced by either malonate or 3-nitropropionic acid (3-NP) were significantly larger in DLST(+/-) mice than in wildtype controls. DLST deficiency enhanced the 3-NP inhibition of mitochondria enzymes, and 3-NP induced protein and DNA oxidations. These observations support the hypothesis that reductions in KGDHC may impair the adaptability of the brain and contribute to the pathogenesis of neurodegenerative diseases.

publication date

  • August 4, 2009

Research

keywords

  • Genetic Predisposition to Disease
  • Ketoglutarate Dehydrogenase Complex
  • Mitochondria
  • Neurotoxins

Identity

PubMed Central ID

  • PMC3605719

Scopus Document Identifier

  • 70349777278

Digital Object Identifier (DOI)

  • 10.1016/j.nbd.2009.07.023

PubMed ID

  • 19660549

Additional Document Info

volume

  • 36

issue

  • 2